The big pharma will spend up to $250 million over the next eight years of the collaboration. Elsewhere, CRISPR Therapeutics unveiled new data and Vivo Capital raised funds.

A Monash-led international study has found a cholesterol-lowering drug may offer a more effective and convenient way to ...

A discussion about screening for Lp(a), a factor that can contribute to hypertension, with Wenjun Fan, MD, PhD, and Arya Aminorroaya, MD, MPH.

Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted H.C. Wainwright 3 rd Annual BioConnect Investor Conference on May 20, 2025, at 10 a.m. ET. The live ...

Health experts have expressed serious concerns over the growing prevalence of high cholesterol levels among the population, warning that this could trigger an alarming increase in heart-related ...

High levels of bad cholesterol (LDL) can clog arteries, increase the risk of heart disease and stroke, and often result from ...

A groundbreaking study reveals that high lipoproteina levels raise heart attack and stroke risks in both Asians and Europeans urging global attention to this hidden threat ...